Oxolinic acid

CAS No. 14698-29-4

Oxolinic acid ( NSC 110364; Urinox )

Catalog No. M12008 CAS No. 14698-29-4

Oxolinic acid is a potent inhibitor of DNA gyrase and DNA synthesis, lead to DNA cleavage when extracted chromosomes are incubated with sodium dodecyl sulfate.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Oxolinic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxolinic acid is a potent inhibitor of DNA gyrase and DNA synthesis, lead to DNA cleavage when extracted chromosomes are incubated with sodium dodecyl sulfate.
  • Description
    Oxolinic acid is a potent inhibitor of DNA gyrase and DNA synthesis, lead to DNA cleavage when extracted chromosomes are incubated with sodium dodecyl sulfate.
  • Synonyms
    NSC 110364; Urinox
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    bacterial DNA gyrase; DNA synthesis; dopamine uptake
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    14698-29-4
  • Formula Weight
    261.24
  • Molecular Formula
    C13H11NO5
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 0.003mg/L
  • SMILES
    O=C(C1=CN(CC)C2=CC(OCO3)=C3C=C2C1=O)O
  • Chemical Name
    5-Ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jariyawat S, et al. J Pharmacol Exp Ther. 1999 Aug;290(2):672-7.
molnova catalog
related products
  • β-Lactamase-IN-1

    β-Lactamase-IN-1 is a β-Lactamase inhibitor and targets the infection of Neisseria gonorrhoeae.

  • CHEMBL1380345

    CHEMBL1380345 exhibits antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli with pMIC values of 3.64, 3.56, and 3.70, respectively.

  • Icariside I

    Icariin is isolated from Epimedium herb. It can stimulate osteogenic differentiation of BMSCs and inhibit bone resorption activity of osteoclasts.